VIZR - An automated chemometric technique for metabolic profiling

Analytical and Bioanalytical Chemistry

Volumn 405, Issue 26, 2013, Pages 8409-8417

  Barding, Gregory A ^a   Orr, Daniel J ^a   Sathnur, Sumukh M ^a   Larive, Cynthia K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biomarker detection; Chemometrics; Disease detection; Metabolomics; Metabonomics; NMR spectroscopy; Toxicological profiling; Z score

Indexed keywords

BODY FLUIDS; DIAGNOSIS; DIETARY SUPPLEMENTS; DISEASE CONTROL; MASS SPECTROMETRY; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OPEN SOURCE SOFTWARE; OPEN SYSTEMS;

BIOMARKER DETECTION; CHEMOMETRIC TECHNIQUES; CHEMOMETRICES; DISEASE DETECTION; METABOLOMICS; METABONOMICS; TEST SAMPLES; TOXICOLOGICAL PROFILING; VISUAL INTERPRETATION; Z-SCORES;

BIOMARKERS;

ANALGESIC AGENT; IBUPROFEN;

ALCOHOLIC BEVERAGE; ARTICLE; DRUG EFFECT; FEMALE; HUMAN; MALE; METABOLOME; METABOLOMICS; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; URINALYSIS;

ALCOHOLIC BEVERAGES; ANALGESICS, NON-NARCOTIC; FEMALE; HUMANS; IBUPROFEN; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOME; METABOLOMICS; URINALYSIS;

EID: 84885430814     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-013-7254-x     Document Type: Article

References (44)

1. Napoli C, Sperandio N, Lawlor RT, Scarpa A, Molinari H, Assfalg M (2012) Urine metabolic signature of pancreatic ductal adenocarcinoma by H-1 nuclear magnetic resonance: identification, mapping, and evolution. J Proteome Res 11:1274-1283
2. Zhang A, Sun H, Wang X (2012) Serum metabolomics as a novel diagnostic approach for disease: a systematic review. Anal Bioanal Chem 404:1239-1245
3. Meng J, Zhang X, Wu H, Bu J, Shi C, Deng C, Mao Y (2012) Morphine-induced conditioned place preference in mice: metabolomic profiling of brain tissue to find "molecular switch" of drug abuse by gas chromatography/mass spectrometry. Anal Chim Acta 710:125-130
4. Aimetti M, Cacciatore S, Graziano A, Tenori L (2012) Metabonomic analysis of saliva reveals generalized chronic periodontitis signature. Metabolomics 8:465-474
5. Holmes E, Foxall PJD, Spraul M, Farrant RD, Nicholson JK, Lindon JC (1997) 750 MHz H-1 NMR spectroscopy characterisation of the complex metabolic pattern of urine from patients with inborn errors of metabolism: 2-hydroxyglutaric aciduria and maple syrup urine disease. J Pharm Biomed Anal 15:1647-1659
6. De Meyer T, Sinnaeve D, Van Gasse B, Rietzschel ER, De Buyzere ML, Langlois MR, Bekaert S, Martins JC, Van Criekinge W (2010) Evaluation of standard and advanced preprocessing methods for the univariate analysis of blood serum H-1-NMR spectra. Anal Bioanal Chem 398:1781-1790
7. Beckonert O, Keun HC, Ebbels TMD, Bundy JG, Holmes E, Lindon JC, Nicholson JK (2007) Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc 2:2692-2703
8. Bollard ME, Stanley EG, Lindon JC, Nicholson JK, Holmes E (2005) NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition. NMR Biomed 18:143-162
9. Wikoff WR, Gangoiti JA, Barshop BA, Siuzdak G (2007) Metabolomics identifies perturbations in human disorders of propionate metabolism. Clin Chem 53:2169-2176
10. Ebbels TMD, Keun HC, Beckonert OP, Bollard ME, Lindon JC, Holmes E, Nicholson JK (2007) Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach. J Proteome Res 6:4407-4422
11. Nicholson J, Keun H, Ebbels T (2007) COMET and the challenge of drug safety screening. J Proteome Res 6:4098-4099
12. Schicho R, Shaykhutdinov R, Ngo J, Nazyrova A, Schneider C, Panaccione R, Kaplan GG, Vogel HJ, Storr M (2012) Quantitative metabolomic profiling of serum, plasma, and urine by H-1 NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals. J Proteome Res 11:3344-3357
13. Gebregiworgis T, Powers R (2012) Application of NMR metabolomics to search for human disease biomarkers. Comb Chem High Throughput Screen 15:595-610
14. Kind T, Tolstikov V, Fiehn O, Weiss RH (2007) A comprehensive urinary metabolomic approach for identifying kidney cancer. Anal Biochem 363:185-195
15. Issaq HJ, Waybright TJ, Veenstra TD (2011) Cancer biomarker discovery: opportunities and pitfalls in analytical methods. Electrophoresis 32:967-975
16. Fiehn O (2002) Metabolomics - the link between genotypes and phenotypes. Plant MolBiol 48:155-171
17. Hamersky KA, Merrywell CE, Fang F, Larive CK (2008) Metabolic profiling. In: Holzgrabe U, Wawer I, Diehl B (eds) NMR spectroscopy in pharmaceutical analysis. Elsevier, Oxford, pp 233-267
18. Zhang AH, Sun H, Wang P, Han Y, Wang XJ (2012) Modern analytical techniques in metabolomics analysis. Analyst 137:293-300
19. Barding G, Salditos R, Larive C (2012) Quantitative NMR for bioanalysis and metabolomics. Anal Bioanal Chem 404:1165-1179
20. Brown FF, Campbell ID, Kuchel PW, Rabenstein DC (1977) Human erythrocyte metabolism studies by H-1 spin-echo NMR. FEBS Lett 82:12-16
21. Bales JR, Higham DP, Howe I, Nicholson JK, Sadler PJ (1984) Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin Chem 30:426-432
22. 1H-NMR studies of vertebrate blood and plasma. Biochem J 211:605-615
23. Fonville JM, Maher AD, Coen M, Holmes E, Lindon JC, Nicholson JK (2010) Evaluation of full-resolution J-resolved H-1 NMR projections of biofluids for metabonomics information retrieval and biomarker identification. Anal Chem 82:1811-1821
24. Craig A, Cloareo O, Holmes E, Nicholson JK, Lindon JC (2006) Scaling and normalization effects in NMR spectroscopic metabonomic data sets. Anal Chem 78:2262-2267
25. Dieterle F, Ross A, Schlotterbeck G, Senn H (2006) Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in H-1 NMR metabonomics. Anal Chem 78:4281-4290
26. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS (2003) Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41:1-12
27. Pearson K (1901) On lines and planes of closest fit to systems of points in space. Philos Mag 2:559-572
28. Trygg J (2002) O2-PLS for qualitative and quantitative analysis in multivariate calibration. J Chemom 16:283-293
29. Trygg J, Wold S (2002) Orthogonal projections to latent structures (O-PLS). J Chemom 16:119-128
30. Broadhurst DI, Kell DB (2006) Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Metabolomics 2:171-196
31. Li H, Wang L, Yan XZ, Liu QJ, Yu CH, Wei HD, Li YM, Zhang XM, He FC, Jiang Y (2011) A proton nuclear magnetic resonance metabonomics approach for biomarker discovery in nonalcoholic fatty liver disease. J Proteome Res 10:2797-2806
32. McKenzie JS, Donarski JA, Wilson JC, Charlton AJ (2011) Analysis of complex mixtures using high-resolution nuclear magnetic resonance spectroscopy and chemometrics. Prog Nucl Magn Reson Spectrosc 59:336-359
33. Ahmed S, Santosh W, Kumar S, Christlet HTT (2009) Metabolic profiling of Parkinson's disease: evidence of biomarker from gene expression analysis and rapid neural network detection. J Biomed Sci 16:12
34. Charlton AJ, Robb P, Donarski JA, Godward J (2008) Non-targeted detection of chemical contamination in carbonated soft drinks using NMR spectroscopy, variable selection and chemometrics. Anal Chim Acta 618:196-203
35. Wei S, Zhang J, Liu L, Ye T, Gowda GAN, Tayyari F, Raftery D (2011) Ratio analysis nuclear magnetic resonance spectroscopy for selective metabolite identification in complex samples. Anal Chem 83:7616-7623
36. Hwang TL, Shaka AJ (1995) Water suppression that works. Excitation sculpting using arbitrary waveforms and pulsed field gradients. J Magn Reson Ser A 112:275-279
37. Henningsen A, Toomet O (2011) miscTools: Miscellaneous tools and utilities. R package version 0.6-12 edn
38. Team RC (2012) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
39. Cheadle C, Vawter MP, Freed WJ, Becker KG (2003) Analysis of microarray data using Z score transformation. J Mol Diag 5:73-81
40. Spraul M, Hofmann M, Dvortsak P, Nicholson JK, Wilson ID (1992) Liquid-chromatography coupled with high-field proton NMR for profiling human urine for endogenous compounds and drug metabolites. J Pharm Biomed Anal 10:601-605
41. Wilson ID, Nicholson JK (1987) Solid-phase extraction chromatography and nuclear magnetic resonance spectrometry for the identification and isolation of drug metabolites in urine. Anal Chem 59:2830-2832
42. Wilson ID, Nicholson JK (1988) Solid-phase extraction chromatography and NMR-spectroscopy (SPEC-NMR) for the rapid identification of drug metabolites in urine. J Pharm Biomed Anal 6:151-165
43. Saude EJ, Adamko D, Rowe BH, Marrie T, Sykes BD (2007) Variation of metabolites in normal human urine. Metabolomics 3:439-451
44. Ramautar R, Nevedomskaya E, Mayboroda OA, Deelder AM, Wilson ID, Gika HG, Theodoridis GA, Somsen GW, de Jong GJ (2011) Metabolic profiling of human urine by CE-MS using a positively charged capillary coating and comparison with UPLC-MS. Mol Biosyst 7:194-199